Serological biomarkers at hospital admission and hospitalization treatments are not related to the development of post-COVID dyspnea

Eur J Intern Med. 2024 Jan:119:132-135. doi: 10.1016/j.ejim.2023.11.004. Epub 2023 Nov 7.
No abstract available

Publication types

  • Letter

MeSH terms

  • Biomarkers
  • COVID-19*
  • Dyspnea / etiology
  • Hospitalization
  • Hospitals
  • Humans

Substances

  • Biomarkers